MicroCap Movers: ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, MMCP in

New Post Public Reply Private Reply Replies (0) Message Board
louied91
68
MicroCap Movers: ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, MMCP in the News

https://thestreetreports.com/microcap-movers-...-the-news/

A wave of micro-cap companies including ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, and MMCP is gaining traction as new developments across biotech, AI, infrastructure, and critical minerals signal accelerating momentum heading into 2026.

iSpecimen Inc. (NASDAQ: ISPC) Streamlines Global Biospecimen Delivery is executing a major operational upgrade with a shift to a decentralized, supplier-to-customer logistics model. The move eliminates legacy delays tied to centralized hubs, cutting delivery times from 7–14 days down to as little as 1–2 days domestically—an improvement of up to 85%. The streamlined approach reduces costs while enhancing efficiency, positioning ISPC to meet growing demand in time-sensitive clinical research and precision medicine markets.

ADM Endeavors Inc. (OTCQB: ADMQ) Expands with New Texas Headquarters and Retail Division is advancing its growth strategy through consolidation into a new Fort Worth headquarters, designed to improve coordination, increase production efficiency, and streamline fulfillment. The company is also launching a new retail division focused on workwear and medical scrubs, “Ariat” supported by partnerships tied to Boot Barn Holdings Inc. (NYSE: BOOT). With expanded capacity and centralized operations, ADMQ expects revenue growth alongside improved margins.

Rapid Dose Therapeutics Corp. (CSX: DOSE / OTCQB: RDTCF) Targets Pharmaceutical Expansion andis upgrading its Burlington manufacturing facility to meet Health Canada Drug Establishment Licence (DEL) requirements, a key regulatory milestone enabling pharmaceutical production and commercialization. The initiative supports expansion of its QuickStrip™ oral thin film technology across global markets, enhancing drug delivery efficiency, bioavailability, and patient compliance. The move signals DOSE.CN’s evolution into a broader pharmaceutical platform.

CS Diagnostics Corp. (OTCQB: CSDX) Advances Hydrogel Technology in Oncology
CSDX continues developing its CS-Protect Hydrogel platform, designed to simplify radiation therapy procedures. Initially targeting prostate cancer, the company is exploring broader applications across multiple oncology indications. Recent patent filings, manufacturing partnerships, and financing efforts highlight its early-stage push into the growing hydrogel spacer market.

American Lithium Minerals Inc. (OTC: AMLM) Strengthens Chilean Copper-Silver Position is expanding its exposure to critical minerals through a secured convertible note investment in Aeramentum Resources in Chile. The move strengthens its foothold in a developing copper–silver district while aligning with broader efforts to secure lithium, copper, and rare earth assets essential to global electrification and energy transition trends.

Mag Mile Capital Inc. (MMCP) Delivers Strong 2025 Financial Growth reported nearly 100% revenue growth in 2025, reaching $4.06 million, alongside significant improvements in gross margin and operating cash flow. Increased deal flow, expansion into CMBS originations, and a focus on larger, complex financings contributed to performance gains. The company is positioning itself to capitalize on evolving commercial real estate financing opportunities.

YXT.com Ltd. (YXT) Expands AI-Driven Enterprise Solutions reported 2025 revenue growth with a notable increase in gross margin to 68.3%, driven by a strategic shift toward enterprise clients and AI-powered solutions. While net losses persist, adjusted losses narrowed significantly, and AI-related recurring revenue is gaining traction. The company is focusing on large enterprise accounts to drive long-term, stable growth in the corporate learning and productivity sector.

MicroCap Watchlist: ISPC, ADMQ, DOSE.CN, YXT, CSDX, AMLM, MMCP
key themes are emerging—operational efficiency, regulatory advancement, AI integration, and strategic asset expansion. As investors continue scanning for under-the-radar opportunities, these micro-cap names are increasingly appearing on watchlists as potential early-stage movers across high-growth sectors.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 95

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 25

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 128

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 60

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 20

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 27

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 186

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 84

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Prostate Treatment Program Launches in Dallas

Updated Category News Views 191

Transforming Prostate Care with the TULSA Program The landscape of prostate treatment is evolving, thanks to the groundbreaking advancements brought forth by Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) and its launch of the TULSA program in collaboration with Texas Prostate and Dallas Medical Center. This pioneering initiative aims to cater to the rising need for...

Continue Reading
Addex Expands Share Capital for Future Financial Flexibility

Updated Category News Views 254

Recent Developments at Addex Therapeutics Ad Hoc Announcement Addex Therapeutics, a clinical-stage biopharmaceutical firm, has made a significant move by issuing 34,300,000 new registered shares. These shares, issued by Addex Pharma S.A, a wholly-owned subsidiary, allow the company to strategically increase its issued share capital to CHF 2,186,544.96. This adjustment...

Continue Reading
Jasper Therapeutics Receives Major Boost from Oppenheimer's $80 Target

Updated Category News Views 130

Oppenheimer Affirms Positive Outlook for Jasper Therapeutics Jasper Therapeutics (NASDAQ:JSPR) has recently captured the attention of investors, particularly following Oppenheimer's announcement of its continued support with an Outperform rating and a notable price target set at $80. The positive sentiment originates from the recent findings of a Phase 1b/2a clinical...

Continue Reading
Taylor Morrison Launches New Resort Community Near Jacksonville

Updated Category News Views 286

Taylor Morrison Launches New Resort Community Near Jacksonville In an exciting development for homebuyers, Taylor Morrison, recognized as one of America’s Most Trusted® Home Builders, has officially broken ground on its first resort lifestyle community in the Jacksonville area. This ambitious project, named Esplanade at St. Marys, spans an impressive 1,250 acres and is...

Continue Reading
Middlefield Canadian Income PCC Report: NAV Insights

Updated Category News Views 123

Understanding Middlefield Canadian Income PCC's Financial Position Middlefield Canadian Income PCC is a notable player in the investment landscape, focusing on generating sustainable income from a diversified portfolio. Understanding its net asset value (NAV) is crucial for investors looking to gauge the company's financial stability and growth potential. Current Net...

Continue Reading